48th week of 2020 patent applcation highlights part 8 |
Patent application number | Title | Published |
20200368124 | GRANULAR COMPOSITE CONTAINING KERATIN AND HEXAGONAL PLATE-LIKE ZINC OXIDE | 2020-11-26 |
20200368125 | FAST-ACTING BIOCIDAL CLEANSING COMPOSITION | 2020-11-26 |
20200368126 | Oral Care Compositions | 2020-11-26 |
20200368127 | Oral Care Compositions | 2020-11-26 |
20200368128 | CLEANING COMPOSITONS, KITS, AND METHODS INCLUDING GLUCAMINE DERIVATIVES | 2020-11-26 |
20200368129 | COMPOSITION FOR DYEING KERATIN FIBERS CONTAINING A COMBINATION OF A P-PHENYLENE DERIVATIVE AND 2,7-NAPHTHALENEDIOL AND USE THEREOF FOR REDUCING A YELLOW TINGE IN A HAIRSTYLE | 2020-11-26 |
20200368130 | HAIR COSMETIC | 2020-11-26 |
20200368131 | OIL-BASED COMPOSITION | 2020-11-26 |
20200368132 | Cleansing Composition Comprising a Nonionic / Cationic Surfactant Mixture | 2020-11-26 |
20200368133 | SUNSCREEN AGENT COMPRISING CELLULOSE NANOFIBERS | 2020-11-26 |
20200368134 | POWDER COSMETIC COMPOSITION CONTAINING STARCH | 2020-11-26 |
20200368135 | USE OF NON-DISSOLVED STARCH BASED PARTICLES | 2020-11-26 |
20200368136 | POLYELECTROLYTE DENTAL ADHESIVES FOR WHITENING TEETH AND TEETH COMPONENTS | 2020-11-26 |
20200368137 | Odorless UV Curable Monomer Solution | 2020-11-26 |
20200368138 | ORAL CARE PARTICLES AND SYSTEM FOR THE ADMINISTRATION THEREOF | 2020-11-26 |
20200368139 | SPF-ENHANCED WATER-RELEASING SUNSCREEN COMPOSITION | 2020-11-26 |
20200368140 | PROCESS FOR DYEING HAIR COMPRISING AT LEAST ONE PIGMENT, AT LEAST ONE ACRYLATE-FUNCTIONALIZED POLYMER AND AT LEAST ONE FUNCTIONALIZED SILICONE CHOSEN FROM SILICONES FUNCTIONALIZED WITH AT LEAST ONE MERCAPTO OR THIOL GROUP | 2020-11-26 |
20200368141 | Ultraviolet Ray Blocking Mixture | 2020-11-26 |
20200368142 | COSMETIC COMPOSITION FOR IMPROVING SKIN CONDITION COMPRISING MIXTURE OF BRASSICA OLERACEA VAR. ACEPHALA SEAWATER EXTRACT, NASTURTIUM OFFICINALE SEAWATER EXTRACT AND BETA VULGARIS ROOT SEAWATER EXTRACT | 2020-11-26 |
20200368143 | SIRTUIN-1 ACTIVATION AGENT AND SKIN COSMETIC FOR ACTIVATING SIRTUIN 1 | 2020-11-26 |
20200368144 | EXTRACTS OF HALIMIONE PORTULACOIDES AND THEIR APPLICATION | 2020-11-26 |
20200368145 | SKIN EXTERNAL COMPOSITION CONTAINING AN EXTRACT OF A FERMENTED PRODUCT OF RED YEAST RICE | 2020-11-26 |
20200368146 | METHOD OF COSMETIC PRESERVATION | 2020-11-26 |
20200368147 | METHODS OF TREATING EOSINOPHILIC ESOPHAGITIS | 2020-11-26 |
20200368148 | ABUSE DETERRENT IMMEDIATE RELEASE FORMULATIONS COMPRISING NON-CELLULOSE POLYSACCHARIDES | 2020-11-26 |
20200368149 | Topical Anesthetic Composition and Method of Synthesis | 2020-11-26 |
20200368150 | SENSITIZATION CREAM COMPRISING L-ARGININE AND L-CITRULLINE AND THERAPEUTIC USES THEREOF | 2020-11-26 |
20200368151 | NASAL COMPOSITION | 2020-11-26 |
20200368152 | LIQUID DEPOT FOR NON-INVASIVE SUSTAINED DELIVERY OF AGENTS TO THE EYE | 2020-11-26 |
20200368153 | EYE DROP FORMULATION AND METHOD FOR SUSTAINED DELIVERY OF MEDICAMENT TO THE RETINA | 2020-11-26 |
20200368154 | COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS | 2020-11-26 |
20200368155 | COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS | 2020-11-26 |
20200368156 | Dry Powder Compositions for Intranasal Delivery | 2020-11-26 |
20200368157 | Inhalable Dry Powder Cytidine Analogue Composition and Method of Use as a Treatment for Cancer | 2020-11-26 |
20200368158 | INHALED PREPARATION OF ISOGLYCYRRHIZIC ACID OR SALT THEREOF, AND USE IN PREPARING DRUGS FOR TREATING RESPIRATORY SYSTEM DISEASES | 2020-11-26 |
20200368159 | AQUEOUS FORMULATION FOR INSOLUBLE DRUGS | 2020-11-26 |
20200368160 | ANTIFUNGAL NANOPARTICLES FOR TARGETED TREATMENT OF FUNGAL INFECTIONS | 2020-11-26 |
20200368161 | Tumor pH-shiftable coating and the nucleus-directed nanoparticles facilitate the targeted chemotherapy and gene therapy against multiple cancers and use thereof | 2020-11-26 |
20200368162 | Nucleic Acid-Based Therapy of Muscular Dystrophies | 2020-11-26 |
20200368163 | ENCAPSULATED WATER-DISPERSIBLE CANNABINOID NANOPARTICLE COMPOSITIONS, METHODS AND SYSTEMS | 2020-11-26 |
20200368164 | POLY(ESTER UREA)S FOR SHAPE MEMORY AND DRUG DELIVERY | 2020-11-26 |
20200368165 | PROCESS AND DEVICE FOR PREPARING A SOLID DISPERSION | 2020-11-26 |
20200368166 | Oral Formulations And Uses Thereof | 2020-11-26 |
20200368167 | COMPOSITIONS | 2020-11-26 |
20200368168 | METHOD FOR PREPARING ELECTROSPRAYING PARTICLES TO IMPROVE STABILITY OF POLYPHENOL | 2020-11-26 |
20200368170 | A LIPID NANOPARTICLE COMPOSITION AND A PHARMACEUTICAL COMPOSITION FOR TREATING A HEMATOPROLIFERATIVE DISORDER | 2020-11-26 |
20200368171 | PARTICLES | 2020-11-26 |
20200368172 | VACCINE DELIVERY SYSTEMS USING YEAST CELL WALL PARTICLES | 2020-11-26 |
20200368173 | NUCLEIC ACID-CONTAINING LIPID NANOPARTICLE | 2020-11-26 |
20200368174 | PARTICLES FOR TARGETED DELIVERY OF ACTIVE AGENTS INTO ADIPOSE STROMAL CELLS | 2020-11-26 |
20200368175 | METHODS AND DEVICES FOR TREATING LEVODOPA INDUCED DYSKINESIA | 2020-11-26 |
20200368176 | Composition comprising amino acid polymers and a bioactive agent and method of preparing thereof | 2020-11-26 |
20200368177 | METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS | 2020-11-26 |
20200368178 | METHOD FOR PREVENTING THE FORMATION OF CALCIFIED DEPOSITS AND FOR INACTIVATING XENOANTIGENS IN BIOLOGICAL MATRICES | 2020-11-26 |
20200368179 | USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY | 2020-11-26 |
20200368180 | Deacetylnemorone Abietane Diterpenoids for Use in Cancer Treatment | 2020-11-26 |
20200368181 | METHODS OF TREATING ANTI-NMDAR-ASSOCIATED NEUROPSYCHIATRIC DISORDERS | 2020-11-26 |
20200368182 | TOXIC ALDEHYDE RELATED DISEASES AND TREATMENT | 2020-11-26 |
20200368183 | METHODS FOR TREATING CANCER | 2020-11-26 |
20200368184 | METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS | 2020-11-26 |
20200368185 | COMBINATION FORMULATION CONTAINING SUSTAINED RELEASE METFORMIN AND IMMEDIATE RELEASE HMG-COA REDUCTASE INHIBITOR | 2020-11-26 |
20200368186 | METHOD FOR MODULATING METABOLISM | 2020-11-26 |
20200368187 | GAMMA-HYDROXYBUTYRATE COMPOSITIONS HAVING IMPROVED PHARMACOKINETICS IN THE FED STATE | 2020-11-26 |
20200368188 | THREONATE COMPOUNDS AND METHODS OF USE THEREOF | 2020-11-26 |
20200368189 | COMPOSITIONS OF BIOACTIVE FULVATE FRACTIONS AND USES THEREOF | 2020-11-26 |
20200368190 | METHODS OF TREATMENT | 2020-11-26 |
20200368191 | USING PROBENECID TO TREAT POLYCYSTIC KIDNEY DISEASE | 2020-11-26 |
20200368192 | TREATMENT OF HYPERAMMONEMIA IN PATIENTS WITH RENAL INSUFFICIENCY | 2020-11-26 |
20200368193 | DEUTERATED ANALOGS OF D-SERINE AND USES THEREOF | 2020-11-26 |
20200368194 | AMINO ACID COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF DISEASE | 2020-11-26 |
20200368195 | HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF | 2020-11-26 |
20200368196 | GLUTAMINASE INHIBITOR THERAPY | 2020-11-26 |
20200368197 | PHARMACEUTICAL COMPOSITION, EXCIPIENT FOR THE COMPOSITION AND USE OF THE COMPOSITION | 2020-11-26 |
20200368198 | METHODS FOR INCREASING FERTILITY | 2020-11-26 |
20200368199 | COMPOSITION CONTAINING SUMO INHIBITOR AND APPLICATION | 2020-11-26 |
20200368200 | ENALAPRIL FORMULATIONS | 2020-11-26 |
20200368201 | NOVEL METHODS | 2020-11-26 |
20200368202 | METHODS FOR THE TREATMENT OF DISEASES AMELIORATED BY PDE4 INHIBITION USING DOSAGE TITRATION OF APREMILAST | 2020-11-26 |
20200368203 | Use Of A Carbamate Compound To Prevent, Alleviate Or Treat Visceralgia Or Pain Arising From Visceral Disease | 2020-11-26 |
20200368204 | COMPOUNDS FOR INHIBITING NS3 AND COMPOSITIONS CONTAINING THE INHIBITED PROTEIN | 2020-11-26 |
20200368205 | METHODS AND COMBINATION THERAPY TO TREAT CANCER | 2020-11-26 |
20200368206 | COMPOSITIONS AND METHODS FOR DELIVERY OF MACROMOLECULES | 2020-11-26 |
20200368207 | GANETESPIB-CONTAINING PARTICLE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND THEIR USE IN ANTICANCER TREATMENT | 2020-11-26 |
20200368208 | Protein Translation Inhibitors and Uses Thereof | 2020-11-26 |
20200368209 | PRAMIPEXOLE TRANSDERMAL DELIVERY SYSTEM AND USES THEREOF | 2020-11-26 |
20200368210 | DUAL INHIBITORS OF TIM-3 AND PD-1 PATHWAYS | 2020-11-26 |
20200368211 | INHIBITION OF GAMMA-GLUTAMYLTRANSFERASE AND GLUTATHIONE CATABOLISM TO ENHANCE THE EFFICACY OF NF-KB SIGNALLING PATHWAY INHIBITORS | 2020-11-26 |
20200368212 | RIFAXIMIN | 2020-11-26 |
20200368213 | METHODS OF TREATING HEPATIC ENCEPHALOPATHY | 2020-11-26 |
20200368214 | INHALABLE FORMULATION OF A SOLUTION CONTAINING VILANTEROL TRIFENATATE AND UMECLIDINIUM BROMIDE | 2020-11-26 |
20200368215 | COMPOSITIONS COMPRISING BERBERINE | 2020-11-26 |
20200368216 | TREATMENT OF SUNBURN USING ANALGESICS AND ANTIHISTAMINES | 2020-11-26 |
20200368217 | SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION | 2020-11-26 |
20200368218 | REPURPOSING COMPOUNDS FOR THE TREATMENT OF INFECTIONS AND FOR MODULATING THE COMPOSITION OF THE GUT MICROBIOME | 2020-11-26 |
20200368219 | PHARMACEUTICAL COMPOSITION INCLUDING MULTI-UNIT SPHEROIDAL TABLET CONTAINING ESOMEPRAZOLE AND SPHEROIDAL PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND METHOD OF PREPARING THE PHARMACEUTICAL COMPOSITION | 2020-11-26 |
20200368220 | Treatment of Aging-Associated Disease with Modulators of Leukotriene A4 Hydrolase | 2020-11-26 |
20200368221 | SOLID PARTICLE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SOLID PARTICLE | 2020-11-26 |
20200368222 | METHODS OF TREATING RADIATION INDUCED GASTROINTESTINAL SYNDROME (RIGS) AND RELATED DISEASE STATES USING YEL002/BCN057 | 2020-11-26 |
20200368223 | METHODS FOR INHIBITING PHOSPHATE TRANSPORT | 2020-11-26 |
20200368225 | PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF DEPRESSION, ANXIETY, AND NEURODEGENERATIVE DISORDERS | 2020-11-26 |